The mRNA and protein levels of PARG, PARP1, and NF-κB p65 were downregulated by BXD, suggesting that BXD may suppress the malignant characteristics of colon cancer cells by modulating the PARG/PARP1/NF-κB signaling pathway [38]. The gene discussed is PARP1; the disease is colonic neoplasm.